Natural products – Page 5

Identification of a Biosynthetic Gene Cluster for the Production of the Blue-Green Pigment Xylindein by the Fungus Chlorociboria aeruginascens

mycolabadmin

Scientists discovered the genetic instructions that allow certain fungi to produce xylindein, a beautiful blue-green pigment found in stained wood. By analyzing fungal genomes and studying gene activity, they identified nine genes working together to create this valuable compound, which has uses in textiles and electronics. While attempts to produce xylindein in laboratory yeasts were unsuccessful, their work successfully produced a related pigment and opens new pathways for understanding xylindein production.

Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products

mycolabadmin

This review examines a group of rare fungal compounds called incisterols, with a focus on demethylincisterol A3 (DM-A3), which has shown promise as an anticancer agent. DM-A3 works through multiple mechanisms including blocking cancer cell signaling pathways, inhibiting specific enzymes, and reducing inflammation. The compound has demonstrated effectiveness against various cancer types in laboratory studies and showed tumor-reducing effects in animal models, suggesting potential for future cancer therapy development.

Comment on Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2

mycolabadmin

This is a scientific critique of a recent study claiming that a plant extract called Bi121 has antiviral properties against SARS-CoV-2. The author raises important concerns about how the plant material was prepared and characterized, noting that the chemical fingerprint appears suspiciously identical to a previously published extract, and that the identification of the active ingredient relies on incomplete evidence. The critique calls for more rigorous scientific methods to verify the original study’s findings.

Anti-Xanthine Oxidase 5′-Hydroxyhericenes A–D from the Edible Mushroom Hericium erinaceus and Structure Revision of 3-[2,3-Dihydroxy-4-(hydroxymethyl)tetrahydrofuran-1-yl]-pyridine-4,5-diol

mycolabadmin

Researchers isolated new compounds from Lion’s mane mushroom (Hericium erinaceus) that can inhibit xanthine oxidase, an enzyme linked to breast cancer development. One compound called hericerin showed strong activity against a specific type of breast cancer cell (T47D cells) while being less harmful to normal cells. The study also corrected a misidentification from previous research, confirming that a compound previously thought to have a different structure was actually adenosine. These findings suggest Lion’s mane could be developed into a natural anti-cancer treatment.

Potential of Indonesian Herbal as an Anti-Cancer Therapy: A Systemic Review of in vitro Studies

mycolabadmin

This review examined eight Indonesian herbal plants that show promise in laboratory studies for fighting various types of cancer. Soursop leaves were the most researched and consistently showed the ability to kill or slow cancer cells in test tubes by triggering natural cell death pathways. The herbs work through bioactive compounds like flavonoids and alkaloids that can interfere with how cancer cells divide and survive. While these results are encouraging, more research is needed to confirm effectiveness in humans.

From Mushrooms to Molecules: Exploring Depsidones in Ganoderma lucidum for Antioxidant and Anticancer Applications

mycolabadmin

This research examined reishi mushroom (Ganoderma lucidum), a traditional medicinal fungus, to find rare compounds called depsidones with potential cancer-fighting properties. Scientists extracted these compounds using different solvents and tested them against four types of cancer cells (liver, colon, breast, and lung cancer), finding that they successfully killed cancer cells while being safe to normal cells. Using advanced chemical analysis and computer modeling, they identified nine new depsidone compounds in reishi and showed how these compounds could bind to cancer-related proteins to stop tumor growth.

Characterizing antimicrobial activity of environmental Streptomyces spp. and oral bacterial and fungal isolates from Canis familiaris and Felis catus

mycolabadmin

Researchers collected bacteria and fungi from the mouths of pet dogs and cats, as well as environmental soil bacteria, to search for natural antimicrobial compounds. They found that some of these microorganisms produce substances that can kill harmful bacteria like E. coli and fungi like Candida albicans, especially when combined with existing antifungal medications. Notably, one environmental bacterium (Streptomyces) produced a compound that was even effective against fungal strains resistant to common antifungal drugs, suggesting promising new treatment possibilities.

Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

mycolabadmin

Scientists discovered a special bacterium called Streptomyces formicae living with plant-ants in Africa that produces powerful antibiotics. This bacterium can kill dangerous drug-resistant bacteria and fungi that are hard to treat with current medicines. By using genetic tools, researchers are unlocking the bacterium’s hidden potential to create many more new antibiotics that could help fight infections.

Extraction and Identification of the Bioactive Metabolites Produced by Curvularia inaequalis, an Endophytic Fungus Collected in Iran from Echium khuzistanicum Mozaff

mycolabadmin

Scientists discovered a beneficial fungus living inside the leaves of an Iranian medicinal plant. They isolated three compounds from this fungus, with the main compound showing powerful activity against drug-resistant bacteria and plant-damaging fungi. This discovery suggests that beneficial fungi within plants could be valuable sources for developing new medicines and natural pesticides.

Mycochemistry, antioxidant activity and anticancer potentiality of ethyl acetate extract of Daldinia eschscholtzii against A549 lung cancer cell line

mycolabadmin

Researchers studied a wild fungus called Daldinia eschscholtzii to see if it could fight lung cancer. They found that an extract from this fungus contained 28 different beneficial compounds and was effective at killing cancer cells by triggering a process called apoptosis (programmed cell death). The treatment also reduced the cancer cells’ ability to spread, and it appeared safe for normal, healthy cells. Several compounds in the extract showed promise as potential anti-cancer drugs.

Research Topic: Natural products